Activation of T cells recognizing self 60-kD heat shock protein can protect against experimental arthritis

Lewis rats are susceptible to several forms of experimental arthritis- induced using heat-killed Mycobacterium tuberculosis (adjuvant arthritis, or AA), streptococcal cell walls, collagen type II, and the lipoidal amine CP20961. Prior immunization with the mycobacterial 65-kD heat shock protein (hsp65) was reported to protect against AA, and other athritis models not using M. tuberculosis, via a T cell-mediated mechanism. Hsp65 shares 48% amino acid identity with mammalian hsp60, which is expressed at elevated levels in inflamed synovia. Several studies have reported cross-reactive T cell recognition of mycobacterial hsp65 and self hsp60 in arthritic and normal individuals. We previously described nine major histocompatibility complex class II- restricted epitopes in mycobacterial hsp65 recognized by Lewis rat T cells. Of these only one, covering the 256-270 sequence, primed for cross-reactive T cell responses to the corresponding region of rat hsp60. Here we have tested each hsp65 epitope for protective activity by immunizing rats with synthetic peptides. A peptide containing the 256-270 epitope, which induced cross-reactive T cells, was the only one able to confer protection against AA. Similarly, administration of a T cell line specific for this epitope protected against AA. Preimmunization with the 256-270 epitope induced T cells that responded to heat-shocked syngeneic antigen-presenting cells, and also protected against CP20961-induced arthritis, indicating that activation of T cells, recognizing an epitope in self hsp60 can protect against arthritis induced without mycobacteria. Therefore, in contrast to the accepted concept that cross-reactive T cell recognition of foreign and self antigens might induce aggressive autoimmune disease, we propose that cross-reactivity between bacterial and self hsp60 might also be used to maintain a protective self-reactive T cell population. This discovery might have important implications for understanding T cell- mediated regulation of inflammation.

[1]  W. van Eden,et al.  Differential mycobacterial 65-kDa heat shock protein T cell epitope recognition after adjuvant arthritis-inducing or protective immunization protocols. , 1994, Journal of immunology.

[2]  F. Calcinaro,et al.  Effect of adjuvant therapy on development of diabetes in mouse and man , 1994, The Lancet.

[3]  W. Paul,et al.  Lymphocyte responses and cytokines , 1994, Cell.

[4]  H. Weiner,et al.  Epitopes of myelin basic protein that trigger TGF-beta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression. , 1993, Journal of immunology.

[5]  S. Anderton,et al.  Inflammation activates self hsp60‐specific T cells , 1993, European journal of immunology.

[6]  A. Miller,et al.  Dominance and crypticity of T cell antigenic determinants. , 1993, Annual review of immunology.

[7]  W. van Eden,et al.  Adjuvant arthritis and immunity to the mycobacterial 65 kDa heat shock protein. , 1992, International immunology.

[8]  W. van Eden,et al.  Two monoclonal antibodies generated against human hsp60 show reactivity with synovial membranes of patients with juvenile chronic arthritis , 1992, The Journal of experimental medicine.

[9]  J. D. Capra,et al.  Peptide recognition, T cell receptor usage and HLA restriction elements of human heat‐shock protein (hsp) 60 and mycobacterial 65‐kDa hsp‐reactive T cell clones from rheumatoid synovial fluid , 1992, European journal of immunology.

[10]  U. Feige,et al.  Prevention of adjuvant arthritis in rats by a nonapeptide from the 65‐kD mycobacterial heat shock protein: specificity and mechanism , 1992, Clinical and experimental immunology.

[11]  J. Bijlsma,et al.  Recognition of human 60 kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis , 1991, The Lancet.

[12]  I. Cohen,et al.  Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[13]  L. Klareskog,et al.  A Monoclonal Antibody to the Mycobacterial 65kDa Heat Shock Protein (ML 30) Binds to Cells in Normal and Arthritic Joints of Rats , 1991, Scandinavian journal of immunology.

[14]  G. Rook,et al.  Autoimmune reactions to heat‐shock proteins in pristane‐induced arthritis , 1990, European journal of immunology.

[15]  U. Feige,et al.  Prevention of adjuvant arthritis in rats by a nonapeptide from the 65‐kD mycobacterial heat‐shock protein , 1990, Clinical and experimental immunology.

[16]  L. Klareskog,et al.  Presence of Human 65 kD Heat Shock Protein (hsp) in Inflamed Joints and Subcutaneous Nodules of RA Patients , 1990, Scandinavian Journal of Immunology.

[17]  M. Colston,et al.  A mycobacterial 65-kD heat shock protein induces antigen-specific suppression of adjuvant arthritis, but is not itself arthritogenic , 1990, The Journal of experimental medicine.

[18]  R. Young,et al.  T lymphocytes from healthy individuals with specificity to self-epitopes shared by the mycobacterial and human 65-kilodalton heat shock protein. , 1989, Journal of immunology.

[19]  W. van Eden,et al.  Protection against streptococcal cell wall-induced arthritis by pretreatment with the 65-kD mycobacterial heat shock protein , 1989, The Journal of experimental medicine.

[20]  C. Harley,et al.  Primary structure of a human mitochondrial protein homologous to the bacterial and plant chaperonins and to the 65-kilodalton mycobacterial antigen , 1989, Molecular and cellular biology.

[21]  R. Young,et al.  Stress proteins may provide a link between the immune response to infection and autoimmunity. , 1989, International immunology.

[22]  I. Cohen,et al.  Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis , 1988, Nature.

[23]  O. Kohashi,et al.  Suppressive effect of Escherichia coli on adjuvant-induced arthritis in germ-free rats. , 1986, Arthritis and rheumatism.

[24]  C. Pearson,et al.  Adjuvant polyarthritis. IV. Induction by a synthetic adjuvant: immunologic, histopathologic, and other studies. , 1980, Arthritis and rheumatism.

[25]  K. Umehara,et al.  Susceptibility to adjuvant-induced arthritis among germfree, specific-pathogen-free, and conventional rats , 1979, Infection and immunity.

[26]  W. J. Cromartie,et al.  Arthritis in rats after systemic injection of streptococcal cells or cell walls , 1977, The Journal of experimental medicine.

[27]  C. Pearson Development of Arthritis, Periarthritis and Periostitis in Rats Given Adjuvants.∗ , 1956, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.